Loading...
Loading...
Guided therapeutic sessions using psychedelic compounds (psilocybin, MDMA, ayahuasca) to catalyze psychological breakthroughs and healing.
83/100
Various (MAPS, Johns Hopkins, Imperial College)
1-3 dosing sessions over 2-6 months with integration therapy
9 phases
5 targeted
Guided therapeutic sessions using psychedelic compounds (psilocybin, MDMA, ayahuasca) to catalyze psychological breakthroughs and healing. Preparation, dosing session, and integration therapy. Emerging FDA-approved treatments.
Revolutionary results: MDMA 67% PTSD remission vs 33% placebo in Phase 3 trials. Psilocybin shows rapid antidepressant effects. FDA approved MDMA-assisted therapy 2024. Legal only in clinical trials or specific jurisdictions. Underground therapy exists. Set and setting critical. Not recreational use.
About Evidence Score
The Evidence Score rates the strength of clinical and scientific evidence behind this protocol. Higher scores indicate stronger research support. This is a research tool, not medical advice.
Educational purposes only. Some alternative protocols carry serious risks. Always consult qualified healthcare professionals before beginning any treatment.